Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Daniel Furst, M.D.
Daniel Furst, M.D.

Specialty:

Rheumatology

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Professor, Department of Medicine
Physician, Department of Medicine, Rheumatology and Arthritis
Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:
Clinical Pharmacology, UCSF Department of Medicine and Medical Specialties, 1975–1977
Rheumatology, UCLA School of Medicine, 1973–1975
Residency:
Internal Medicine, Johns Hopkins University School of Medicine, 1969–1970
Internship:
Internal Medicine, Johns Hopkins University School of Medicine, 1968–1969
Medical Degree:
M.D., Johns Hopkins University School of Medicine, 1968

Certification(s):

Medical Board Certification(s):
Rheumatology, American Board of Internal Medicine, 1996
Internal Medicine, American Board of Internal Medicine, 1974

Contact Information:

Rheumatology and Arthritis:
(310) 825-2448 Information and referral
Email:

Practice Information:

Clinical Interest(s):
Osteoarthritis
Rheumatoid Arthritis
Scleroderma

Scientific Interest(s):

Dr. Daniel Furst's research interests are in the clinical pharmacology of drugs used to treat rheumatic and autoimmune diseases, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs and biological modifiers. He also has an ongoing interest in scleroderma's pathogenesis, measurement and treatment.

Furst has published more than 300 articles and 10 books. He has served or is serving on the editorial board of Inpharma, Clinical Drug Invest, Drugs, The Journal of Clinical Rheumatology and The Journal of Rheumatology. Additionally, he is an editorial reviewer for professional publications including Arthritis & Rheumatism, New England Journal of Medicine, Journal of Clinical Investigation, Pharmacotherapy and Journal of Rheumatology.